Home Details
| Official Symbol of Gene | HLA-A |
| Species | Homo sapiens |
| Entrez Gene ID | 3105 |
| Official Full Name | major histocompatibility complex, class I, A |
| Also known as | HLAA |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000206503 MIM:142800; AllianceGenome:HGNC:4931 |
| Map Location | 6p22.1 |
| Variation Type | allele |
| refSNP ID | N/A |
| Detected Sample | peripheral blood |
| Sample Detail | N/A |
| Detected Method | sequence-specific oligonucleotide (SSO) method |
| Disease | MS |
| Disease subtype | RRMS,PPMS,SPMS |
| Population | Norwegian and Swedish |
| Sample Size | 286 of the Norwegian and 576 of the Swedish patients |
| Pubmed ID | 17662002 |
| Year | 2007 |
| Title | The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients |
| Risk Type | Phenotypic risk |
| Main Result | Negative |
| Result | This study could not identify any significant contribution from HLA-A on the clinical phenotype in MS. |
| Mechanism/Pathway | Human leucocyte antigen (HLA) complex on chromosome 6p21 is the only locus that has consistently been shown to be associated with MS. |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.